Alliance News: “The UK jobs data released yesterday was grim: more than 250,000 jobs have been lost since October’s budget announcement. Higher taxes are weighing on employment and sustaining inflationary pressure, complicating the Bank of England’s policy outlook. Still, markets are increasingly pricing in rate cuts amid signs of further weakness.”
Comment: The socialist government has perfectly delivered the socialist policy of impoverishing the nation, so more people are forced to vote Labour for welfare. In the latest example, another 250,000 who have lost their jobs. This is a deliberate policy / action, not incompetence.
Solvonis Therapeutics (SVNS), a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, announced the initiation of an artificial intelligence (“AI”) supported drug discovery programme focused on its proprietary central nervous system (“CNS”) compound library. Under the scientific leadership of Professor David Nutt, Solvonis’ Chief Scientific Officer, the AI enabled programme will initially prioritise indications in depression and stimulant use disorders.
Comment: SVNS is already showing with its newsflow to be on the money as far as its technology, as well as being focused on the disorders with the greatest need. The valuation of the company at still only £13m is very much an entry level opportunity.
Valereum (AQSE: VLRM) announced that Nick Cowan will be stepping down as CEO, with immediate effect, following the unsuccessful completion of the DMC deal. We would like to extend our sincere gratitude to Nick for his leadership and dedication during his time with the Company, and we wish him all the best in his future endeavours. A total of 10,000,000 warrants previously allocated to Nick Cowan have been cancelled. VLRM said “Valereum is now heading for the global stage, and the proposed Board changes emphasise the expertise and experience required to take the next step.”
Comment: It was a bit harsh perhaps to cancel Cowan’s warrants. As far as VLRM being on the global stage, the recent past the decline from 30p to 4.2p as DMC ran off (remember Walk This Way), will take some getting back from.
Celadon Pharmaceuticals (CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines, announces that further to the 6 June 2025 announcement, it has entered into a new £0.5 million (gross) one year unsecured credit facility with a European based high net worth individual lender (the “Lender”) (the “New Facility”) and has received funds totalling £0.5 million.
Comment: After persistently baiting the company over the past couple of months, the bears will be upset that CEL has managed to dodge the Grim Reaper for at least a temporary reprieve.
The boards of WSP Global, WSP UK and Ricardo (RCDO) announced that they have reached agreement on the terms of a recommended final* cash acquisition pursuant to which WSP UK, or another wholly-owned subsidiary of WSP Global, will acquire the entire issued and to be issued share capital of Ricardo other than the Ricardo.
Comment: Shares of RCDO have been rising like a homesick angel in the past few sessions, suggesting that everyone and their mother new this deal was on its way. And for journalists who do not understand the stock market, it is good news when a company gets taken over, that is what being listed is for.
Hydrogen Utopia International (HUI), a company specialising in turning non-recyclable mixed waste plastic into hydrogen and other carbon-free fuels, new materials or distributed renewable heat, announced that, further to the announcement of 6 June 2025, it has raised gross proceeds of £250,000 at the price of £0.0175 per share under existing unspent share authorities.
Comment: A timely raise for HUI in the wake of last week’s MENA waste-hydrogen announcement breakthrough. One would consider the company is now funded to execute the rollout. Note the shares are already trading well above the placing price.
Premier African Minerals (PREM) announced a subscription today to raise £1,575 million before expenses at an issue price of 0.012 pence per new ordinary share (“Issue Price”) for the Zulu Lithium and Tantalum Project. In addition, the Company has settled US$1.1 million (equivalent to £0.740 million) worth of contractor’s invoices of Zulu through the issue of 6,174,166,667 new ordinary shares in the Company at the Issue Price.
Comment: Like Banquo’s ghost x 2, we have both George Roach and a placing, just in case anyone thought it was the end of an era. Apparently, not quite.
Helium One Global (HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development project in Colorado, USA, provides the following update on the current status of the award of the Mining Licence in Tanzania. Negotiation of Regulatory Framework Agreements being finalised. Government free carried interest agreed at 17%.
Comment: Shares of HE1 are up today, underlining the way that no one really cares about the company’s diversionary US investment, it is all about Rukwa. We see the way that the mining license application still has some steps to go, meaning that the company will continue to have to lean on US newsflow.
Capital Metals (CMET), a mineral sands company approaching mine development stage at the high-grade Taprobane Minerals Project in Sri Lanka, updated on drilling within the northern EL168 area, focusing on the Initial Mining Area of the existing 17.2 Mt Mineral Resource. CMET said “”We are delighted with the initial observations from Phase 1 drilling. Whilst results are only estimates at this stage, extensive new mineralisation discovery is evident. This confirms our exploration model and validates our expectation of a substantial resource increase.”
Comment: A substantial resource increase would certainly be what the doctor ordered, and something which should more than get the CMET share price back on the right side of the one year resistance at 5p.
Reabold Resources (RBD), the investing company focussed on developing strategic gas projects for European energy security, today announced its audited financial results for the year ended 31 December 2024 and the Annual Report is publicly available at www.reabold.com/investors/reports-presentations/.
Comment: RBD shares continue to trade under cash, which whatever one thinks of this surprisingly unpopular company, represented a value opportunity, at least in theory according to the great and the good on social media.
Thor Explorations (THX) announced that Mr. Chris Omo-Osagie, Chief Financial Officer, purchased 200,000 Common Shares on 06 June, 2025. Mr. Omo-Osagie retains a beneficial interest in 300,000 Common Shares representing approximately 0.045% of the total issued share capital in the Company.
Comment: Director buying at the highs can be in this instance taken as providing confidence that shares of THX are set to rise yet further on the 137% so far this year.
Coinsilium Group Limited (AQSE: COIN) provided an update on its Bitcoin treasury activity and that of its wholly owned Gibraltar subsidiary, Forza Gibraltar Limited, established to implement the Company’s dedicated Bitcoin-focused treasury operations. Details of the latest Bitcoin acquisition are as follows: Number of Bitcoin Purchased: 5.0416. Average Purchase Price: £81,323.39 per Bitcoin ($109,954.42 per Bitcoin). Total Purchase Amount: £410,000.
Comment: In the race to be the hottest Bitcoin Treasury company on the UK stock market, we have COIN playing catch up versus the mighty SWC. That said, some may suggest that currently it is COIN which is the value play out of the two, if only in market cap terms.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
